Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
1 result
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
CRISPR-Cas9-based non-viral gene editing therapy for topical treatment of recessive dystrophic epidermolysis bullosa.
Mol Ther Methods Clin Dev. 2023 Oct 13;31:101134. doi: 10.1016/j.omtm.2023.101134. eCollection 2023 Dec 14.
Mol Ther Methods Clin Dev. 2023.
PMID: 38027067
Free PMC article.
Cite
Cite